Pages that link to "Q46011485"
Jump to navigation
Jump to search
The following pages link to PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats. (Q46011485):
Displaying 31 items.
- Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation (Q28390202) (← links)
- Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. (Q30359347) (← links)
- PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms (Q30434858) (← links)
- Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling (Q33759937) (← links)
- Chromatin regulation by Brg1 underlies heart muscle development and disease (Q33969388) (← links)
- Helicobacter pylori activation of PARP-1: usurping a versatile regulator of host cellular health (Q34664112) (← links)
- Chromatin remodeling in cardiovascular development and physiology (Q34814306) (← links)
- PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade (Q35061401) (← links)
- Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy (Q35176333) (← links)
- PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension (Q35437493) (← links)
- Nebulization with γ-tocopherol ameliorates acute lung injury after burn and smoke inhalation in the ovine model (Q35836662) (← links)
- Active components from Radix Scrophulariae inhibits the ventricular remodeling induced by hypertension in rats (Q36712276) (← links)
- Therapeutic applications of PARP inhibitors: anticancer therapy and beyond (Q36853236) (← links)
- PKCα and HMGB1 antagonistically control hydrogen peroxide-induced poly-ADP-ribose formation (Q37264322) (← links)
- Genetics and epigenetics of arrhythmia and heart failure (Q37267318) (← links)
- Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies (Q37835753) (← links)
- Epigenetics and chromatin remodeling in adult cardiomyopathy (Q38118214) (← links)
- Moxonidine improves cardiac structure and performance in SHR through inhibition of cytokines, p38 MAPK and Akt. (Q38739980) (← links)
- Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases (Q38954348) (← links)
- Decreasing P-selectin and ICAM-1 via activating Akt: a possible mechanism by which PARG inhibits adhesion of mouse colorectal carcinoma CT26 cells to platelets (Q39109788) (← links)
- The effects of B0, B20, and B100 soy biodiesel exhaust on aconitine-induced cardiac arrhythmia in spontaneously hypertensive rats (Q40378275) (← links)
- Alterations in early filling dynamics predict the progression of compensated pressure overload hypertrophy to heart failure better than abnormalities in midwall systolic shortening. (Q43424401) (← links)
- Poly(ADP-ribose)polymerase 1 inhibition protects against age-dependent endothelial dysfunction (Q46675845) (← links)
- Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure. (Q47283225) (← links)
- Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats. (Q54543875) (← links)
- PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NF‑κB in tumour metastases of colon carcinoma (Q64122901) (← links)
- PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy (Q64376823) (← links)
- Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy (Q89964211) (← links)
- SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity (Q90090945) (← links)
- The cardioprotective effect of dexrazoxane (Cardioxane) is consistent with sequestration of poly(ADP-ribose) by self-assembly and not depletion of topoisomerase 2B (Q91818012) (← links)
- The Effects of Bradykinin B1 Receptor Antagonism on the Myocardial and Vascular Consequences of Hypertension in SHR Rats (Q92617396) (← links)